Quick Answer
AtriCure, Inc. reported Stockholders Equity of $491.94 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +6.7% in Stockholders Equity from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $14.94 million | Q3 2012: $13.56 million | Q1 2013: $38.60 million | Q2 2013: $38.14 million | Q3 2013: $36.25 million | Q1 2014: $134.26 million | Q2 2014: $134.22 million | Q3 2014: $135.04 million | Q1 2015: $128.56 million | Q2 2015: $128.69 million | Q3 2015: $125.48 million | Q1 2016: $181.03 million | Q2 2016: $177.00 million | Q3 2016: $173.43 million | Q1 2017: $160.86 million | Q2 2017: $161.50 million | Q3 2017: $158.92 million | Q1 2018: $153.12 million | Q2 2018: $159.69 million | Q3 2018: $163.77 million | Q1 2019: $239.29 million | Q2 2019: $241.55 million | Q3 2019: $258.22 million | Q1 2020: $227.37 million | Q2 2020: $416.86 million | Q3 2020: $417.53 million | Q1 2021: $391.24 million | Q2 2021: $385.08 million | Q3 2021: $488.47 million | Q1 2022: $462.83 million | Q2 2022: $456.71 million | Q3 2022: $450.31 million | Q1 2023: $454.85 million | Q2 2023: $462.42 million | Q3 2023: $462.83 million | Q1 2024: $456.31 million | Q2 2024: $462.09 million | Q3 2024: $465.02 million | Q1 2025: $454.62 million | Q2 2025: $464.49 million | Q3 2025: $476.51 million.
- Over the full 14 years of available data (2012 to 2025), AtriCure, Inc.'s Stockholders Equity has grown by 3,835.5%.
- Historical annual values: Fiscal year 2025: $491.94 million | Fiscal year 2024: $460.97 million | Fiscal year 2023: $466.17 million | Fiscal year 2022: $456.75 million | Fiscal year 2021: $483.76 million | Fiscal year 2020: $412.39 million | Fiscal year 2019: $247.34 million | Fiscal year 2018: $249.38 million | Fiscal year 2017: $161.17 million | Fiscal year 2016: $168.44 million | Fiscal year 2015: $186.69 million | Fiscal year 2014: $132.54 million | Fiscal year 2013: $72.60 million | Fiscal year 2012: $12.50 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: